# A Study of ONO-1110 in Patients With Major Depressive Disorder

> **NCT06792136** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Major Depressive Disorder (MDD

## Interventions

- **DRUG:** ONO-1110
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06792136
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-16
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06792136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06792136, "A Study of ONO-1110 in Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06792136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*